| Pharm - Neurology | 37 | May 10, 2012 |
| Pharm - Psychiatry | 13 | May 10, 2012 |
| Pharm - Respiratory | 16 | May 10, 2012 |
| Pharm - Reproductive | 18 | May 10, 2012 |
| Pharm - Renal | 7 | May 10, 2012 |
| Pharm - Musculoskeletal | 8 | May 10, 2012 |
| Pharm - Hematology/Oncology | 29 | May 10, 2012 |
| Pharm - Gastrointestinal | 11 | May 10, 2012 |
| Pharm - Endocrine | 16 | May 10, 2012 |
| Pharm - Immunosuppressants | 22 | May 10, 2012 |
| ToRCHS infections | 6 | May 9, 2012 |
| Rashes of childhood | 7 | May 9, 2012 |
| HLA subtypes with associated diseases | 8 | May 9, 2012 |
| Important cytokines | 16 | May 9, 2012 |
| Hypersensitivity reactions | 4 | May 9, 2012 |
| Immune Deficiencies | 14 | May 9, 2012 |
| Autoantibodies | 20 | May 9, 2012 |
| Disease inheritance | 28 | May 9, 2012 |
| Glycogen storage diseases | 4 | May 9, 2012 |
| Lysosomal storage diseases | 8 | May 9, 2012 |
| Major apolipoproteins, lipases, enzymes | 11 | May 9, 2012 |
| Major apolipoproteins, lipases, enzymes | 11 | May 9, 2012 |
| Lipoprotein functions | 5 | May 9, 2012 |
| Familial Dyslipidemias | 4 | May 9, 2012 |
| Pharm - Cardiovascular | 22 | May 3, 2012 |
| Signaling pathways of endocrine hormones | 7 | May 3, 2012 |
| Pharm - Antibiotics | 49 | May 2, 2012 |
| Rate-determining enzymes of metabolic processes | 13 | April 30, 2012 |
| Paraneoplastic effects of tumors | 6 | April 30, 2012 |
| Chemical carcinogens | 9 | April 30, 2012 |
| Oncogenic microbes | 8 | April 30, 2012 |
| Tumor suppressor genes | 11 | April 30, 2012 |
| Oncogenes | 9 | April 30, 2012 |
| Disease conditions associated with neoplasms | 16 | April 30, 2012 |
| Drug Reactions | 45 | April 30, 2012 |
| Most common/important associations | 134 | April 29, 2012 |
| Classic/Relevant Treatments | 91 | April 29, 2012 |
| Classic Labs/findings | 99 | April 29, 2012 |
| Drug Names | 25 | April 29, 2012 |
| Antidotes | 22 | April 29, 2012 |